Archive: 17/02/2016
Nanotechnology treatment reprograms immune cells to reverse autoimmune disease
Parvus Therapeutics today announced the publication in Nature of a seminal paper describing the discovery and applications of a novel therapeutic approach employing nanomedicines, referred to as "Navacims", to reprogram white ...
Feb 17, 2016
Inovio sees human trials of Zika vaccine in 2016
US biotech company Inovio Pharmaceuticals said Wednesday it has had promising test results on a Zika virus vaccine in mice and plans to launch clinical trials on humans this year.
Feb 17, 2016
Autoantibodies may help detect lung cancer earlier
Preliminary research has identified autoantibodies, immune proteins found in the blood specific for one's own proteins, that can potentially detect lung cancer early by distinguishing between smokers with or without lung ...
Feb 17, 2016
Researchers publish on connection between anal cancer, HPV
Researchers at Women & Infants Hospital, a Care New England hospital, recently published the results of a study demonstrating a connection between anal cancer and human papillomavirus (HPV) infection.
Feb 17, 2016
Low-dose exposure of environmental contaminants can be harmful to the human brain
Individuals subjected to chronic low-dose exposure to organochlorine pesticides show and increased risk to obtain a future diagnosis of cognitive impairment. This is shown in a study now published in Environmental International.
Feb 17, 2016
Researchers find marked gender differences in scholarly productivity
The differences between men and women seem to infiltrate yet another aspect of medicine with a study spearheaded at Women & Infants Hospital, a Care New England hospital, indicating that younger female gynecologic oncologists ...
Feb 17, 2016